investigational conjugated pneumococcal vaccine

October 1998

There's lots of excitement about an investigational conjugated pneumococcal vaccine...for use in children under age 2.

This will be big...similar to the conjugated Hib vaccines that came on the market almost 10 years ago.

The new vaccine prevents pneumococcal meningitis and bacteremia in children. It's also expected to reduce the incidence of pneumococcal pneumonia and otitis media.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

  • Cutting-edge advice about new medications and how they fit into practice
  • Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
  • Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote